U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 21 to 40 of 96

Tests names and labsConditionsGenes, analytes, and microbesMethods

GTC-Hematology Profile

Genomic Testing Cooperative, LCA
United States
1247
  • C Sequence analysis of the entire coding region

Capillary malformations, congenital, 1, somatic, mosaic, 163000; CMC (Familial multiple nevi flammei) (GNAQ gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Sturge-Weber syndrome, somatic, mosaic, 185300; SWS (Sturge-Weber syndrome) (GNAQ gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Comprehensive HemeComplete Profile with IGH Somatic Hypermutation

PathGroup
United States
13161
  • E Sequence analysis of select exons
  • T Targeted variant analysis

HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and T-Cell Clonality Analysis

PathGroup
United States
23160
  • T Targeted variant analysis

HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and JAK2 V617F Quant

PathGroup
United States
18160
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 IS

PathGroup
United States
17160
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1

PathGroup
United States
17160
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR

PathGroup
United States
16160
  • T Targeted variant analysis

qGenEx Intellectual disability

Quantitative Genomic Medicine Laboratories, SL
Spain
31969
  • S Mutation scanning of the entire coding region
  • C Sequence analysis of the entire coding region

Tempus xF

Tempus Labs, Inc.
United States
1105
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

PrimBio Cancer HotSpot Panel

PrimBio Research Institute
United States
6050
  • T Targeted variant analysis

NeoTYPE® Discovery Profile for Solid Tumors

NeoGenomics Laboratories NeoGenomics Laboratories, Inc.
United States
1315
  • I Immunohistochemistry
  • F Fluorescence in situ hybridization (FISH)
  • C Sequence analysis of the entire coding region

ProvSeq 523

Providence St. Joseph Health Molecular Genomics Laboratory Providence St Joseph Health
United States
1523
  • C Sequence analysis of the entire coding region

Segmental Overgrowth Disorders - NGS panel

Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center, Location AMC
Netherlands
413
  • C Sequence analysis of the entire coding region

Comprehensive Panel for Individualized Cancer Threatment

GeneKor MSA
Greece
1652
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Somatic Overgrowth and Vascular Malformations Gene Panel

Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine
United States
934
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

Comprehensive Epilepsy

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
414800
  • C Sequence analysis of the entire coding region

Vascular Anomalies Panel with interpretation

Clinical Genomics Laboratory Washington University in St. Louis
United States
165
  • C Sequence analysis of the entire coding region

GeneVa

Laboratory for Molecular Pediatric Pathology Boston Children's Hospital
United States
135
  • T Targeted variant analysis

Results: 21 to 40 of 96

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.